Canada Life’s Rhythm Pharmaceuticals RYTM Stock Holding History

Canada Life’s Portfolio RYTM Stock Details RYTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$642K	Hold	5,797	–	–	﹤0.01%	1458
2026 Q1	$507K	Hold	5,797	–	–	﹤0.01%	1499
2025 Q4	$621K	Sell	5,797 -8,598	-60%	-$912K	﹤0.01%	1469
2025 Q3	$1.45M	Buy	14,395 +2,817	+24%	+$262K	﹤0.01%	1335
2025 Q2	$733K	Hold	11,578	–	–	﹤0.01%	1514
2025 Q1	$615K	Hold	11,578	–	–	﹤0.01%	1569
2024 Q4	$648K	Hold	11,578	–	–	﹤0.01%	1585
2024 Q3	$607K	Hold	11,578	–	–	﹤0.01%	1639
2024 Q2	$475K	Buy	11,578 +6,782	+141%	+$271K	﹤0.01%	1689
2024 Q1	$208K	Hold	4,796	–	–	﹤0.01%	1826
2023 Q4	$219K	Buy	4,796 +1,249	+35%	+$39.4K	﹤0.01%	1834
2023 Q3	$81K	Buy	3,547 +1,184	+50%	+$26.5K	﹤0.01%	2008
2023 Q2	$39K	Hold	2,363	–	–	﹤0.01%	2031
2023 Q1	$42K	Hold	2,363	–	–	﹤0.01%	2094
2022 Q4	$69K	Hold	2,363	–	–	﹤0.01%	2038
2022 Q3	$58K	Hold	2,363	–	–	﹤0.01%	2072
2022 Q2	$10K	Hold	2,363	–	–	﹤0.01%	2366
2022 Q1	$29K	Hold	2,363	–	–	﹤0.01%	2284
2021 Q4	$23K	Hold	2,363	–	–	﹤0.01%	2349
2021 Q3	$31K	Hold	2,363	–	–	﹤0.01%	2353
2021 Q2	$46K	Hold	2,363	–	–	﹤0.01%	2297
2021 Q1	$50K	Hold	2,363	–	–	﹤0.01%	2295
2020 Q4	$70K	Hold	2,363	–	–	﹤0.01%	2183
2020 Q3	$51K	Hold	2,363	–	–	﹤0.01%	2176
2020 Q2	$52K	Hold	2,363	–	–	﹤0.01%	2213
2020 Q1	$36K	Hold	2,363	–	–	﹤0.01%	2228
2019 Q4	$54K	Buy	+2,363	New	+$52.5K	﹤0.01%	2238
2019 Q3	–	Sell	-2,610	Closed	-$57K	–	2048
2019 Q2	$57K	Hold	2,610	–	–	﹤0.01%	2410
2019 Q1	$71K	Hold	2,610	–	–	﹤0.01%	2171
2018 Q4	$68K	Buy	+2,610	New	+$72.1K	﹤0.01%	2273

Other funds holding RYTM

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Canada Life's RYTM Position: Q2 2026 in Review

Canada Life held its Rhythm Pharmaceuticals (RYTM) position steady in Q2 2026 at 5,797 shares worth $642K. The position accounts for ﹤0.01% of the portfolio, ranked #1458.

Canada Life first reported a position in RYTM in Q4 2018 and has held it in 30 quarters since. The position peaked at $1.45M in Q3 2025. 304 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

Canada Life held 5,797 shares of Rhythm Pharmaceuticals worth $642K as of Q2 2026.
Canada Life left its Rhythm Pharmaceuticals share count unchanged in Q2 2026.
Rhythm Pharmaceuticals made up ﹤0.01% of Canada Life's portfolio in Q2 2026, its #1458 holding.
Canada Life first reported a position in Rhythm Pharmaceuticals in Q4 2018 and has held it in 30 quarters since.
Canada Life's Rhythm Pharmaceuticals position peaked at $1.45M in Q3 2025.
304 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Canada Life's 13F filing for Q2 2026, filed 13 Aug 2026.